Did you miss our live company presentation with NanoEcho’s CEO, Linda Persson, yesterday? No worries, you can watch it afterwards. The presentation is now also subtitled.
NanoEcho is currently conducting a new share issue to enter the clinical phase with our patented diagnostic method. The goal is to improve healthcare by providing patients with rectal cancer a more accurate diagnosis and personalised treatment.
Learn more about the ongoing share issue: https://lnkd.in/dH_uUs5h.
